Detalhe da pesquisa
1.
Improvement in the prognosis of ovarian cancer in the era before addition of molecular targeting therapy.
Jpn J Clin Oncol
; 47(6): 494-498, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334884
2.
A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer.
Jpn J Clin Oncol
; 45(5): 422-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25670764
3.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
J Clin Oncol
; 39(33): 3671-3681, 2021 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473544
4.
Unprecedented three-step spin-crossover transition in new 2-dimensional coordination polymer {Fe(II)(4-methylpyridine)(2)[Au(I)(CN)(2)](2)}.
Dalton Trans
; 39(7): 1719-21, 2010 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20449412
5.
A new spin crossover heterometallic Fe(II)Ag(I) coordination polymer with the [Ag(2)(CN)(3)](-) unit: crystallographic and magnetic study.
Dalton Trans
; 39(7): 1786-90, 2010 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20449423